Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Randomized consent designs for clinical trials: an update.

M Zelen1

  • 1Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115.

Statistics in Medicine
|June 1, 1990
PubMed
Summary

Randomized consent designs simplify physician participation in clinical trials by addressing concerns about the physician-patient relationship. These designs facilitate patient enrollment in randomized studies, even with placebo controls.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The training of biostatistical scientists.

Statistics in medicine·2003
Same author

Referent sampling, family history and relative risk: the role of length-biased sampling.

Biostatistics (Oxford, England)·2003
Same author

Modelling the early detection of breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2003
Same author

Testing the independence of two diagnostic tests.

Biometrics·2002
Same author

Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Comparing the survival of two groups with an intermediate clinical event.

Lifetime data analysis·2001

Area of Science:

  • Clinical Trials Methodology
  • Medical Ethics
  • Biostatistics

Background:

  • Physician participation in randomized clinical trials (RCTs) is crucial for advancing medical knowledge.
  • Physician reluctance to enroll patients in RCTs often stems from concerns about compromising the physician-patient relationship.
  • The use of no-treatment or placebo controls in RCTs can exacerbate these ethical concerns.

Purpose of the Study:

  • To review the fundamental concepts of single and double randomized consent designs.
  • To explain the underlying statistical model used for analyzing data from randomized consent designs.
  • To present recent practical experiences and outcomes from implementing these designs.

Main Methods:

  • Review of existing literature on randomized consent designs.

Related Experiment Videos

  • Explanation of the statistical framework for analyzing randomized consent trials.
  • Case studies or summaries of recent applications of randomized consent designs.

    • Main Results:

    • Randomized consent designs offer a viable solution to overcome physician reluctance in RCT participation.
    • These designs can be statistically analyzed using established models.
    • Recent experiences demonstrate the feasibility and benefits of implementing randomized consent designs.

    Conclusions:

    • Randomized consent designs effectively address ethical concerns regarding the physician-patient relationship in clinical trials.
    • These designs facilitate increased physician enrollment and patient participation in crucial research.
    • Further adoption of randomized consent designs can enhance the efficiency and ethical conduct of clinical research.